semaglutide approved Novo Nordisk's weight-loss pill wins FDA approval Wegovy approved to help teens

Suddenly, these same people are no longer food-obsessed

2004;53(Suppl 3):S16S21

It did teach me diet por tioncontrol, she says

Potential advantages Often a strong option for patients with significant reflux May be especially helpful for patients with type 2 diabetes or metabolic disease Can be used as a revision option after Lap-Band or sleeve in selected patients May provide more weight loss for some higher-risk or higher-BMI patients Long track record in bariatric and metabolic surgery Important considerations More complex anatomy than gastric sleeve Higher need for lifelong vitamin and mineral compliance Dumping syndrome can occur, especially with high-sugar foods NSAID and steroid use may be restricted because of ulcer risk Requires careful long-term follow-up Which Procedure Might Be the Best Fit

Grapefruit can alter thyroid hormone metabolism in some individuals

Novo Nordisk chose to continue using semaglutide, the same active ingredient found in Wegovy and Ozempic injections